Dr. Eduardo E. Rodriguez, MD

Dr. Rodriguez practices at New Orleans Neuro-Radiosurgery Center in New Orleans, Louisiana.

Dr. Rodriguez's NPI, 1053363515, was assigned on May 16, 2006. Dr. Rodriguez holds Louisiana license 04594R.

Dr. Rodriguez's primary practice is New Orleans Neuro-Radiosurgery Center, at 3434 Prytania St, New Orleans, LA 70115 in Orleans Parish. The practice phone is (317) 536-1351.

Dr. Rodriguez's primary practice is New Orleans Neuro-Radiosurgery Center in New Orleans, Louisiana. Dr. Rodriguez is also affiliated with Touro Infirmary. The medical group on file is Crescent City Physicians, Inc. Dmand AI also links Dr. Rodriguez to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rodriguez practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Rodriguez's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Rodriguez is board certified in internal medicine by the American Board of Internal Medicine. Dr. Rodriguez is licensed in Louisiana.

CMS data shows 667 Medicare services from Dr. Rodriguez across 6 procedure codes in 2024, for 214 Medicare patients. Medicare paid $50,147 for them.

CMS counts 214 Medicare patients who saw Dr. Rodriguez in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rodriguez's median patient age at 75, with 50% women.

In 2024, Dr. Rodriguez wrote 7,023 Medicare Part D claims for 524 patients. 88% of them were for generic drugs. CMS names the drug for 6,376 of them, across 101 drugs with 11 or more claims each, at $472,622 in total drug cost. In 2023, CMS named 6,009 claims across 94 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Rodriguez for performance year 2024, reported as part of a group. Dr. Rodriguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Rodriguez to 1 clinical trial. Conditions studied include Renal Insufficiency, Chronic and Renal Insufficiency. Open Payments lists research payments to Dr. Rodriguez that name 1 trial.

CMS Open Payments shows 455 general payments to Dr. Rodriguez from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Novartis Pharmaceuticals Corporation paid the most, $4,133. It also lists 12 research payments totaling $1,981 from 2018 to 2019, naming 1 clinical trial.